Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Pride 2024: How can pharma leaders make a difference?
Hear from four pharma leaders on the benefits to employees and patients of workplaces that promote inclusivity for the LGBTQ+ community.
Read more
Drugs: it does exactly what it says on the label
Labelling is the vessel through which vital instructions and information about products are communicated to end-users, and in the pharmaceutical industry, medical affairs are entrusted with safeguarding these products from misuse, by balancing scientific accuracy with conciseness and coherence.
Launching the Future of Technology in 3...2...1...
Innovative technology has changed the game in pharma, from AI-powered marketing campaigns to DNA sequencing tools. When this technology is combined with creative thinking, the potential for success is vast. It is critical for pharma to marry creativity with technology as they drive towards a patient-centric future
Almirall’s Francesca Wuttke on the value of digital innovation for patients
Francesca Wuttke, Chief Digital Officer, Almirall, shares her thoughts on how digital transformation, motivation and innovation can change patients’ lives for the better.
Raising the Voices of Rare Disease
Rare diseases are complex conditions, but these patients are highly educated and determined, using platforms such as social media to make strides towards improving knowledge. It is vital that medical affairs executives consult these empowered, expert patients as they uncover unmet needs and think beyond the medication.
Chief Digital Officers: the pioneers of cultural change
Meet the Chief Digital Officer: a person that ensures a pharmaceutical company evolves with the times through continued collaboration and culture shifts.
The metrics of medical affairs
Measuring the impact of medical affairs is less straightforward than it is for R&D or commercial, but we must establish success metrics.
Creating brand loyalty with RWE
The commercial value of RWE is yet to be realised, but the benefits extend far beyond the aisles in which it is currently in high demand.
Calling checkmate on meaningless social media
The pharma industry is dabbling in the game of social media, and it’s no secret that they need to have a better presence on these platforms.
Loading posts...
« Previous
1
…
23
24
25
26
27
…
30
Next »